The Future of
Medical AI
Delivered Weekly
Curated research insights for clinicians and patients. No hype. Just evidence.
Zodasiran for cholesterol and triglyceride lowering in patients with hyperlipidemia: final report of phase 1 basket trial
Zodasiran, an experimental drug, significantly lowers triglycerides and bad cholesterol in patients with high lipid levels, showing promise in early trials.
Why Medical Professionals Choose Mednosis
We cut through the noise to deliver research that actually matters
Built for Clinicians
Technical notes include study design, sample sizes, confidence intervals, and key limitations
Patient-Friendly
Every article includes plain language explanations your patients can understand
Zero Hype Guarantee
Practice impact ratings tell you exactly how close research is to clinical reality
Latest Research
Target product profiles for treatments to delay or prevent symptomatic Alzheimer’s disease
Quality health information for all is a fundamental determinant of health
AI uncovers significant misdiagnoses in carcinoma type, study shows
Young Professional’s AI Tool Spots Mental Health Conditions
Enabling agent-first process redesign
What Does Virtual First Mean In Healthcare?
Get smarter about medical AI every week
Join clinicians and researchers staying ahead of the curve
Trending This Week
Research getting the most attention
Target product profiles for treatments to delay or prevent symptomatic Alzheimer’s disease
Quality health information for all is a fundamental determinant of health
Uncertainty-Guided Latent Diagnostic Trajectory Learning for Sequential Clinical Diagnosis
Find What Matters to You
Filter research by how close it is to clinical practice
Browse by Specialty
Find research relevant to your field
Never Miss a
Breakthrough
Get curated AI in medicine research delivered weekly. No spam, unsubscribe anytime.
AI in Medicine 101
Learn how to read medical AI research, spot red flags in hype-y articles, and ask the right questions about new technologies.